O	0	7	Insulin	Insulin	NN	B-NP
O	7	8	-	-	HYPH	I-NP
O	8	12	like	like	JJ	I-NP
O	13	19	growth	growth	NN	I-NP
O	20	26	factor	factor	NN	I-NP
O	27	28	1	1	CD	I-NP
O	29	37	receptor	receptor	NN	I-NP
O	38	46	enhances	enhance	VBZ	B-VP
O	47	55	invasion	invasion	NN	B-NP
O	56	59	and	and	CC	O
O	60	67	induces	induce	VBZ	B-VP
O	68	78	resistance	resistance	NN	B-NP
O	79	81	to	to	TO	B-PP
O	82	91	apoptosis	apoptosis	NN	B-NP
O	92	94	of	of	IN	B-PP
B-Cell	95	100	colon	colon	NN	B-NP
I-Cell	101	107	cancer	cancer	NN	I-NP
I-Cell	108	113	cells	cell	NNS	I-NP
O	114	121	through	through	IN	B-PP
O	122	125	the	the	DT	B-NP
O	126	129	Akt	Akt	NN	I-NP
O	129	130	/	/	SYM	B-NP
O	130	133	Bcl	Bcl	NN	I-NP
O	133	134	-	-	HYPH	O
O	134	135	x	x	SYM	B-NP
O	135	136	(	(	(	O
O	136	137	L	L	NN	B-NP
O	137	138	)	)	)	O
O	139	146	pathway	pathway	NN	B-NP
O	146	147	.	.	.	O

B-Cancer	149	154	Colon	Colon	NN	B-NP
I-Cancer	155	161	cancer	cancer	NN	I-NP
O	162	175	overexpresses	overexpresse	VBZ	B-VP
O	176	183	insulin	insulin	NN	B-NP
O	183	184	-	-	HYPH	I-NP
O	184	188	like	like	JJ	I-NP
O	189	195	growth	growth	NN	I-NP
O	196	202	factor	factor	NN	I-NP
O	203	204	1	1	CD	I-NP
O	205	206	(	(	(	O
O	206	210	IGF1	IGF1	NN	B-NP
O	210	211	)	)	)	O
O	212	215	and	and	CC	O
O	216	223	insulin	insulin	NN	B-NP
O	223	224	-	-	HYPH	O
O	224	228	like	like	JJ	B-NP
O	229	235	growth	growth	NN	I-NP
O	236	242	factor	factor	NN	I-NP
O	243	244	1	1	CD	I-NP
O	245	253	receptor	receptor	NN	I-NP
O	254	255	(	(	(	O
O	255	259	IGF1	IGF1	NN	B-NP
O	259	260	-	-	HYPH	B-NP
O	260	261	R	R	NN	I-NP
O	261	262	)	)	)	O
O	262	263	,	,	,	O
O	264	266	as	as	IN	B-SBAR
O	267	275	compared	compare	VBN	B-PP
O	276	280	with	with	IN	B-PP
O	281	287	normal	normal	JJ	B-NP
O	288	290	or	or	CC	I-NP
B-Multi-tissue_structure	291	302	adenomatous	adenomatous	JJ	I-NP
I-Multi-tissue_structure	303	309	mucosa	mucosa	NN	I-NP
O	309	310	,	,	,	O
O	311	314	and	and	CC	O
O	315	317	it	it	PRP	B-NP
O	318	321	has	have	VBZ	B-VP
O	322	326	been	be	VBN	I-VP
O	327	337	postulated	postulate	VBN	I-VP
O	338	342	that	that	IN	B-SBAR
B-Cell	343	353	colorectal	colorectal	JJ	B-NP
I-Cell	354	360	cancer	cancer	NN	I-NP
I-Cell	361	366	cells	cell	NNS	I-NP
O	367	373	depend	depend	VBP	B-VP
O	374	376	on	on	IN	B-PP
O	377	380	the	the	DT	B-NP
O	381	385	IGF1	IGF1	NN	I-NP
O	385	386	/	/	SYM	B-NP
O	386	390	IGF1	IGF1	NN	I-NP
O	390	391	-	-	HYPH	B-NP
O	391	392	R	R	NN	I-NP
O	393	400	pathway	pathway	NN	I-NP
O	401	404	for	for	IN	B-PP
O	405	410	their	their	PRP$	B-NP
O	411	417	growth	growth	NN	I-NP
O	418	421	and	and	CC	I-NP
O	422	433	progression	progression	NN	I-NP
O	433	434	.	.	.	O

O	435	437	In	In	IN	B-PP
O	438	442	this	this	DT	B-NP
O	443	448	study	study	NN	I-NP
O	448	449	,	,	,	O
O	450	455	using	use	VBG	B-VP
O	456	459	the	the	DT	B-NP
O	460	465	human	human	JJ	I-NP
B-Cell	466	471	colon	colon	NN	I-NP
I-Cell	472	478	cancer	cancer	NN	I-NP
I-Cell	479	483	cell	cell	NN	I-NP
I-Cell	484	488	line	line	NN	I-NP
I-Cell	489	495	HCT116	HCT116	NN	I-NP
O	495	496	,	,	,	O
O	497	499	we	we	PRP	B-NP
O	500	504	find	find	VBP	B-VP
O	505	509	that	that	IN	B-SBAR
O	510	521	established	establish	VBN	B-NP
B-Cell	522	528	HCT116	HCT116	NN	I-NP
I-Cell	528	529	/	/	SYM	B-NP
I-Cell	529	533	IGF1	IGF1	NN	I-NP
I-Cell	533	534	-	-	HYPH	B-NP
I-Cell	534	535	R	R	NN	I-NP
I-Cell	536	549	transfectants	transfectant	NNS	I-NP
O	550	557	exhibit	exhibit	VBP	B-VP
O	558	559	a	a	DT	B-NP
O	560	564	more	more	RBR	I-NP
O	565	575	aggressive	aggressive	JJ	I-NP
O	576	587	transformed	transform	VBN	I-NP
O	588	597	phenotype	phenotype	NN	I-NP
O	598	602	than	than	IN	B-PP
O	603	606	the	the	DT	B-NP
B-Cell	607	615	parental	parental	JJ	I-NP
I-Cell	616	620	cell	cell	NN	I-NP
I-Cell	621	625	line	line	NN	I-NP
O	625	626	,	,	,	O
O	627	629	as	as	IN	B-SBAR
O	630	642	demonstrated	demonstrate	VBN	B-VP
O	643	645	by	by	IN	B-PP
O	646	651	their	their	PRP$	B-NP
O	652	658	higher	high	JJR	I-NP
O	659	672	proliferation	proliferation	NN	I-NP
O	673	677	rate	rate	NN	I-NP
O	678	680	in	in	IN	B-PP
O	681	689	response	response	NN	I-PP
O	690	692	to	to	TO	I-PP
O	693	697	IGF1	IGF1	NN	B-NP
O	697	698	,	,	,	O
O	699	705	higher	high	JJR	B-NP
O	706	712	degree	degree	NN	I-NP
O	713	715	of	of	IN	B-PP
O	716	725	anchorage	anchorage	NN	B-NP
O	725	726	-	-	HYPH	B-NP
O	726	737	independent	independent	JJ	I-NP
O	738	744	growth	growth	NN	I-NP
O	744	745	,	,	,	O
O	746	756	resistance	resistance	NN	B-NP
O	757	759	to	to	TO	B-PP
B-Organism_substance	760	765	serum	serum	NN	B-NP
O	766	777	deprivation	deprivation	NN	I-NP
O	777	778	-	-	HYPH	B-NP
O	778	785	induced	induce	VBN	I-NP
O	786	795	apoptosis	apoptosis	NN	I-NP
O	795	796	,	,	,	O
O	797	800	and	and	CC	O
O	801	807	higher	high	JJR	B-NP
O	808	817	migratory	migratory	JJ	I-NP
O	818	828	capability	capability	NN	I-NP
O	829	831	in	in	IN	B-PP
O	832	833	a	a	DT	B-NP
B-Cell	834	843	monolayer	monolayer	NN	I-NP
O	844	845	"	"	``	O
O	845	853	wounding	wound	VBG	B-VP
O	854	859	assay	assay	NN	B-NP
O	859	860	.	.	.	O
O	860	861	"	"	''	O
O	862	866	When	When	WRB	B-ADVP
O	867	875	injected	inject	VBN	B-VP
O	876	880	into	into	IN	B-PP
O	881	885	nude	nude	JJ	B-NP
O	886	890	mice	mouse	NNS	I-NP
O	890	891	,	,	,	O
B-Cell	892	898	HCT116	HCT116	NN	B-NP
I-Cell	898	899	/	/	SYM	B-NP
I-Cell	899	903	IGF1	IGF1	NN	I-NP
I-Cell	903	904	-	-	HYPH	B-NP
I-Cell	904	905	R	R	NN	I-NP
I-Cell	906	919	transfectants	transfectant	NNS	I-NP
O	920	924	were	be	VBD	B-VP
O	925	931	highly	highly	RB	B-ADJP
O	932	940	invasive	invasive	JJ	I-ADJP
O	941	944	and	and	CC	O
O	945	953	produced	produce	VBD	B-VP
O	954	961	distant	distant	JJ	B-NP
B-Cancer	962	972	metastases	metastasis	NNS	I-NP
O	972	973	,	,	,	O
O	974	981	whereas	whereas	IN	O
O	982	985	the	the	DT	B-NP
B-Cell	986	994	parental	parental	JJ	I-NP
I-Cell	995	999	cell	cell	NN	I-NP
O	1000	1003	did	do	VBD	B-VP
O	1004	1007	not	not	RB	O
O	1007	1008	.	.	.	O

O	1009	1017	Moreover	Moreover	RB	B-ADVP
O	1017	1018	,	,	,	O
O	1019	1022	the	the	DT	B-NP
O	1023	1037	overexpression	overexpression	NN	I-NP
O	1038	1040	of	of	IN	B-PP
O	1041	1045	IGF1	IGF1	NN	B-NP
O	1045	1046	-	-	HYPH	B-NP
O	1046	1047	R	R	NN	I-NP
O	1048	1050	in	in	IN	B-PP
O	1051	1056	these	these	DT	B-NP
B-Cell	1057	1062	cells	cell	NNS	I-NP
O	1063	1066	was	be	VBD	B-VP
O	1067	1077	associated	associate	VBN	I-VP
O	1078	1082	with	with	IN	B-PP
O	1083	1087	IGF1	IGF1	NN	B-NP
O	1087	1088	-	-	HYPH	B-NP
O	1088	1089	R	R	NN	I-NP
O	1089	1090	-	-	HYPH	B-NP
O	1090	1097	induced	induce	VBN	I-NP
O	1098	1108	activation	activation	NN	I-NP
O	1109	1111	of	of	IN	B-PP
O	1112	1115	Akt	Akt	NN	B-NP
O	1116	1119	and	and	CC	O
O	1120	1122	up	up	RB	B-ADVP
O	1122	1123	-	-	HYPH	B-NP
O	1123	1133	regulation	regulation	NN	I-NP
O	1134	1136	of	of	IN	B-PP
O	1137	1140	the	the	DT	B-NP
O	1141	1154	antiapoptotic	antiapoptotic	JJ	I-NP
O	1155	1162	protein	protein	NN	I-NP
O	1163	1166	Bcl	Bcl	NN	I-NP
O	1166	1167	-	-	HYPH	O
O	1167	1168	x	x	SYM	B-NP
O	1168	1169	(	(	(	O
O	1169	1170	L	L	NN	B-NP
O	1170	1171	)	)	)	O
O	1171	1172	.	.	.	O

O	1173	1175	We	We	PRP	B-NP
O	1176	1180	also	also	RB	B-ADVP
O	1181	1185	show	show	VBP	B-VP
O	1186	1190	that	that	IN	B-SBAR
O	1191	1194	Akt	Akt	NN	B-NP
O	1195	1202	pathway	pathway	NN	I-NP
O	1203	1211	mediates	mediate	VBZ	B-VP
O	1212	1216	IGF1	IGF1	NN	B-NP
O	1216	1217	-	-	HYPH	B-NP
O	1217	1218	R	R	NN	I-NP
O	1218	1219	-	-	HYPH	O
O	1219	1226	induced	induce	VBN	B-NP
O	1227	1230	Bcl	Bcl	NN	I-NP
O	1230	1231	-	-	HYPH	O
O	1231	1232	x	x	SYM	B-NP
O	1232	1233	(	(	(	O
O	1233	1234	L	L	NN	B-NP
O	1234	1235	)	)	)	O
O	1236	1246	expression	expression	NN	B-NP
O	1247	1249	at	at	IN	B-PP
O	1250	1265	transcriptional	transcriptional	JJ	B-NP
O	1266	1271	level	level	NN	I-NP
O	1271	1272	.	.	.	O

O	1273	1276	Our	Our	PRP$	B-NP
O	1277	1281	data	datum	NNS	I-NP
O	1282	1293	demonstrate	demonstrate	VBP	B-VP
O	1293	1294	,	,	,	O
O	1295	1298	for	for	IN	B-PP
O	1299	1302	the	the	DT	B-NP
O	1303	1308	first	first	JJ	I-NP
O	1309	1313	time	time	NN	I-NP
O	1313	1314	,	,	,	O
O	1315	1319	that	that	IN	B-SBAR
O	1320	1324	IGF1	IGF1	NN	B-NP
O	1324	1325	-	-	HYPH	I-NP
O	1325	1326	R	R	NN	I-NP
O	1326	1327	/	/	SYM	I-NP
O	1327	1330	Akt	Akt	NN	I-NP
O	1330	1331	/	/	SYM	B-NP
O	1331	1334	Bcl	Bcl	NN	I-NP
O	1334	1335	-	-	HYPH	O
O	1335	1336	x	x	SYM	B-NP
O	1336	1337	(	(	(	O
O	1337	1338	L	L	NN	B-NP
O	1338	1339	)	)	)	O
O	1340	1347	pathway	pathway	NN	B-NP
O	1348	1351	may	may	MD	B-VP
O	1352	1362	contribute	contribute	VB	I-VP
O	1363	1365	to	to	TO	B-PP
O	1366	1367	a	a	DT	B-NP
O	1368	1372	more	more	RBR	I-NP
O	1373	1383	aggressive	aggressive	JJ	I-NP
O	1384	1393	malignant	malignant	JJ	I-NP
O	1394	1403	phenotype	phenotype	NN	I-NP
O	1403	1404	,	,	,	O
O	1405	1407	in	in	IN	B-PP
O	1408	1409	a	a	DT	B-NP
O	1410	1416	subset	subset	NN	I-NP
O	1417	1419	of	of	IN	B-PP
B-Cancer	1420	1430	colorectal	colorectal	JJ	B-NP
I-Cancer	1431	1438	cancers	cancer	NNS	I-NP
O	1438	1439	.	.	.	O

